Merck & Co Inc (NYSE:MRK)
$ 130.06 -0.17 (-0.13%) Market Cap: 329.42 Bil Enterprise Value: 358.02 Bil PE Ratio: 144.51 PB Ratio: 8.16 GF Score: 88/100

Q4 2019 Merck & Co Inc Earnings Call Transcript

Feb 05, 2020 / 01:00PM GMT
Release Date Price: $81.84 (-2.86%)
Operator

Good morning. My name is Carlo, and I will be your conference operator today. At this time, I would like to welcome everyone to the Merck & Co. quarter 4 sales and earnings conference call. (Operator Instructions)

I would now like to turn the call over to Peter Dannenbaum, VP of Investor Relations. Please go ahead.

Peter Dannenbaum
Merck & Co., Inc. - VP of IR

Thank you, Carlo, and good morning. Welcome to Merck's Fourth Quarter 2019 Conference Call.

Today, I'm joined by Ken Frazier, our Chairman and Chief Executive Officer; Rob Davis, our Chief Financial Officer; Dr. Roger Perlmutter, President of Merck Research Labs; and Kevin Ali, who will be named Chief Executive Officer of the new company we have announced today. Each will have prepared remarks. In addition, I am also joined by Frank Clyburn, our Chief Commercial Officer; and Mike Nally, our Chief Marketing Officer, who will be available for the Q&A portion of the call.

Before I turn the call over to Ken, I'd like to point out a few items. You will see that we have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot